The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Casdin Partners Master Fund, L.p. since 2021.
This trader's CIK number is 1534265.
At the time of last reporting, Casdin Partners Master Fund, L.p. was the 10% Owner of Verve Therapeutics, Inc.. (stock ticker symbol VERV).
Also see all insider trading activities at Verve Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | VERV | 1,100,000 | $20,900,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | DBTX | 575,000 | $10,350,000 | 0 | $0 | 0 | $0 |
1. Verve Therapeutics, Inc. (VERV)
2. Decibel Therapeutics, Inc. (DBTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-21 | VERV | Buy | 1,100,000 | 19.00 | 20,900,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-17 | DBTX | Buy | 575,000 | 18.00 | 10,350,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Casdin Partners Master Fund, L.p. (10% Owner of Verve Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.